{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:02:48Z","timestamp":1791270168514,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1124\/jpet.111.183483","type":"journal-article","created":{"date-parts":[[2011,8,2]],"date-time":"2011-08-02T02:42:20Z","timestamp":1312252940000},"page":"519-529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"title":["Exposure Levels of Anti-LINGO-1 Li81 Antibody in the Central Nervous System and Dose-Efficacy Relationships in Rat Spinal Cord Remyelination Models after Systemic Administration"],"prefix":"10.1016","volume":"339","author":[{"given":"R. Blake","family":"Pepinsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benxiu","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gym","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Walus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christilyn","family":"Graff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Garber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.111.183483_bib1","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/j.1471-4159.2005.03463.x","article-title":"The blood-brain barrier transmigrating single domain antibody: mechanisms of transport and antigenic epitopes in human brain endothelial cells","volume":"95","author":"Abulrob","year":"2005","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.111.183483_bib2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2165\/00063030-200822050-00003","article-title":"Recombinant antibodies as therapeutic agents: pathways for modeling new biodrugs","volume":"22","author":"Aires da Silva","year":"2008","journal-title":"BioDrugs"},{"key":"10.1124\/jpet.111.183483_bib3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0022-3565(24)37211-8","article-title":"Pharmacokinetics of IgG and IgM anti-ganglioside antibodies in rats and monkeys after intrathecal administration","volume":"284","author":"Bergman","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.111.183483_bib4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jbiotec.2010.01.011","article-title":"Selective targeting of a TNFR decoy receptor pharmaceutical to the primate brain as a receptor-specific IgG fusion protein","volume":"146","author":"Boado","year":"2010","journal-title":"J Biotechnol"},{"key":"10.1124\/jpet.111.183483_bib5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/1091581810361527","article-title":"A 4-week intrathecal toxicity and pharmacokinetic study with trastuzumab in cynomolgus monkeys","volume":"29","author":"Braen","year":"2010","journal-title":"Int J Toxicol"},{"key":"10.1124\/jpet.111.183483_bib6","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3171\/jns.1984.61.5.0901","article-title":"Comparison of various methods for delivering radiolabeled monoclonal antibody to normal rat brain","volume":"61","author":"Bullard","year":"1984","journal-title":"J Neurosurg"},{"key":"10.1124\/jpet.111.183483_bib7","doi-asserted-by":"crossref","first-page":"8844","DOI":"10.1523\/JNEUROSCI.23-26-08844.2003","article-title":"In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-\u03b2 metabolism and half-life","volume":"23","author":"Cirrito","year":"2003","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.111.183483_bib8","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1167\/iovs.07-1199","article-title":"Blocking LINGO-1 function promotes retinal ganglion cell survival following ocular hypertension and optic nerve transection","volume":"49","author":"Fu","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1124\/jpet.111.183483_bib9","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1208\/s12248-009-9129-9","article-title":"Investigation of the influence of FcRn on the distribution of IgG to the brain","volume":"11","author":"Garg","year":"2009","journal-title":"AAPS J"},{"key":"10.1124\/jpet.111.183483_bib10","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cbpa.2008.03.019","article-title":"Blood-brain barrier permeability considerations for CNS-targeted compound library design","volume":"12","author":"Hitchcock","year":"2008","journal-title":"Curr Opin Chem Biol"},{"key":"10.1124\/jpet.111.183483_bib11","doi-asserted-by":"crossref","first-page":"14430","DOI":"10.1073\/pnas.0700901104","article-title":"Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson\u2019s disease models","volume":"104","author":"Inoue","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/jpet.111.183483_bib12","series-title":"Guide for the Care and Use of Laboratory Animals","year":"1996"},{"key":"10.1124\/jpet.111.183483_bib13","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.mcn.2006.08.003","article-title":"LINGO-1 antagonist promotes functional recovery and axonal sprouting after spinal cord injury","volume":"33","author":"Ji","year":"2006","journal-title":"Mol Cell Neurosci"},{"key":"10.1124\/jpet.111.183483_bib14","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s00221-006-0752-8","article-title":"IVIG enters the central nervous system during treatment of experimental autoimmune encephalomyelitis and is localised to inflammatory lesions","volume":"178","author":"Jorgensen","year":"2007","journal-title":"Exp Brain Res"},{"key":"10.1124\/jpet.111.183483_bib15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1023\/A:1006995910836","article-title":"Tight junctions of the blood-brain barrier","volume":"20","author":"Kniesel","year":"2000","journal-title":"Cell Mol Neurobiol"},{"key":"10.1124\/jpet.111.183483_bib16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00063030-200923020-00003","article-title":"Strategies to extend plasma half-lives of recombinant antibodies","volume":"23","author":"Kontermann","year":"2009","journal-title":"BioDrugs"},{"key":"10.1124\/jpet.111.183483_bib17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0378-5173(99)00458-5","article-title":"Modulating pharmacokinetics of an anti-interleukin-8 F(ab\u2032)(2) by amine-specific PEGylation with preserved bioactivity","volume":"198","author":"Koumenis","year":"2000","journal-title":"Int J Pharm"},{"key":"10.1124\/jpet.111.183483_bib18","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.coi.2008.05.010","article-title":"When binding is enough: nonactivating antibody formats","volume":"20","author":"Labrijn","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"10.1124\/jpet.111.183483_bib19","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1006\/cyto.2001.0936","article-title":"Adapting pharmacokinetic properties of a humanized anti-interleukin-8 antibody for therapeutic applications using site-specific pegylation","volume":"16","author":"Leong","year":"2001","journal-title":"Cytokine"},{"key":"10.1124\/jpet.111.183483_bib20","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1096\/fj.06-6463fje","article-title":"Insights into the mechanisms of action of anti-A\u03b2 antibodies in Alzheimer\u2019s disease mouse models","volume":"20","author":"Levites","year":"2006","journal-title":"FASEB J"},{"key":"10.1124\/jpet.111.183483_bib21","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/nm1664","article-title":"LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis","volume":"13","author":"Mi","year":"2007","journal-title":"Nat Med"},{"key":"10.1124\/jpet.111.183483_bib22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nn1188","article-title":"LINGO-1 is a component of the Nogo-66 receptor\/p75 signaling complex","volume":"7","author":"Mi","year":"2004","journal-title":"Nat Neurosci"},{"key":"10.1124\/jpet.111.183483_bib23","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nn1460","article-title":"LINGO-1 negatively regulates myelination by oligodendrocytes","volume":"8","author":"Mi","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1124\/jpet.111.183483_bib24","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.21581","article-title":"Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells","volume":"65","author":"Mi","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1124\/jpet.111.183483_bib25","unstructured":"Mi S, Pepinsky RB, Shao Z, Garber EA, Miklasz SD (2009b), inventors; Biogen Idec, Inc., assignee. Sp35 antibodies and uses thereof. U.S. patent application 20090252748. 2009 Aug 8."},{"key":"10.1124\/jpet.111.183483_bib26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrn2995","article-title":"Engaging neuroscience to advance translational research in brain barrier biology","volume":"12","author":"Neuwelt","year":"2011","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/jpet.111.183483_bib27","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/pro.372","article-title":"Improving the solubility of anti-LINGO-1 monoclonal antibody Li33 by isotype switching and targeted mutagenesis","volume":"19","author":"Pepinsky","year":"2010","journal-title":"Protein Sci"},{"key":"10.1124\/jpet.111.183483_bib28","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1021\/bc1002746","article-title":"Production of a PEGylated Fab\u2032 of the anti-LINGO-1 Li33 antibody and assessment of its biochemical and functional properties in vitro and in a rat model of remyelination","volume":"22","author":"Pepinsky","year":"2011","journal-title":"Bioconjug Chem"},{"key":"10.1124\/jpet.111.183483_bib29","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.addr.2004.07.011","article-title":"Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamics","volume":"56","author":"Shen","year":"2004","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/jpet.111.183483_bib30","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1021\/mp1003515","article-title":"Receptor-mediated A\u03b2 amyloid antibody targeting to Alzheimer\u2019s disease mouse brain","volume":"8","author":"Zhou","year":"2011","journal-title":"Mol Pharm"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524466196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524466196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.111.183483","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T22:45:57Z","timestamp":1743201957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524466196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0022356524466196"],"URL":"https:\/\/doi.org\/10.1124\/jpet.111.183483","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exposure Levels of Anti-LINGO-1 Li81 Antibody in the Central Nervous System and Dose-Efficacy Relationships in Rat Spinal Cord Remyelination Models after Systemic Administration","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.111.183483","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}